Mumbai, India – Pulmonary hypertension (PH) is a serious, progressive condition that places immense strain on the heart and lungs, often leading to heart failure if not diagnosed and treated in time. Affecting both children and adults, PH can significantly reduce quality of life, causing symptoms such as breathlessness, fatigue, chest pain, and fainting episodes. Advances in medical science, however, are now transforming outcomes for patients living with this condition, especially when care is led by specialists experienced in complex cardiac and pulmonary interventions.
Dr. Prashant Bobhate, a highly respected Pulmonary Hypertension Specialist in Mumbai, serves as Senior Consultant at the Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital, where he focuses on delivering advanced, evidence-based care for patients with pulmonary hypertension. With over a decade of dedicated experience in pediatric and congenital cardiology, Dr. Bobhate has been instrumental in introducing interventional and surgical strategies that go beyond conventional medical management, offering new hope to patients with severe and progressive disease.
Pulmonary hypertension often develops as a complication of congenital heart disease, lung disorders, or vascular abnormalities. When left untreated, persistently high pressure in the pulmonary arteries forces the right side of the heart to work harder, eventually leading to right heart failure. Dr. Prashant Bobhate emphasizes that timely diagnosis and a tailored treatment plan are critical in altering the disease course. His clinical approach combines precise diagnostic evaluation with carefully selected interventional procedures, ensuring that each patient receives individualized care based on disease severity, age, and underlying cause.
One of the most impactful contributions of Dr. Bobhate’s work has been in the management of advanced pulmonary arterial hypertension through interventional options such as the Potts shunt procedure. This complex surgical technique creates a controlled connection between the pulmonary artery and the aorta, helping to offload pressure from the right side of the heart in carefully selected patients. With one of the highest single-center experiences in India, Dr. Bobhate has helped numerous patients—particularly children with severe disease—experience significant improvement in symptoms, functional capacity, and overall quality of life.
In addition to interventional procedures, Dr. Bobhate has played a key role in improving access to advanced medical therapies for pulmonary hypertension. Certain life-saving medications, such as prostacyclin analogues, have demonstrated clear survival benefits but are not easily available in India. Through persistent clinical efforts and structured treatment pathways, patients under his care have been able to receive these therapies safely, resulting in improved exercise tolerance and reduced disease progression. Many patients who were previously limited by severe breathlessness are now able to return to school, work, and daily activities with minimal symptoms.
Early detection remains a cornerstone of Dr. Bobhate’s philosophy. He strongly advocates screening and early evaluation, particularly in children with congenital heart disease or those showing early signs of pulmonary vascular involvement. Through detailed echocardiographic assessment and cardiac catheterization when required, subtle changes can be identified before irreversible damage occurs.
Beyond procedures and medications, comprehensive care is central to improving long-term outcomes. Patients under Dr. Bobhate’s supervision benefit from coordinated follow-up, functional assessment, and cardiopulmonary rehabilitation where needed. This holistic approach ensures that treatment does not stop at symptom control but extends to physical recovery, emotional reassurance, and long-term disease monitoring.
“Pulmonary hypertension is a condition that requires precision, patience, and persistence,” Dr. Bobhate explains. “With early diagnosis, appropriate interventions, and continuous follow-up, we can significantly improve both survival and quality of life. Every patient deserves access to the right treatment at the right time.”
Dr. Prashant Bobhate’s commitment to advancing pulmonary hypertension care continues to shape outcomes for patients facing this challenging condition. Through innovation, clinical expertise, and a patient-centred mindset, he remains dedicated to pushing the boundaries of what is possible in interventional pulmonary hypertension management.
Dr. Prashant Bobhate
Pediatric Cardiologist | MD (Peds), FNB (Peds Card), FPVRI
Senior Consultant – Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital, Mumbai
+91 8080 826 898
prashantbobhate@gmail.com
Website – https://phindia.net/
